Leap Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Cypherpunk Technologies

18/03/2024 13:31

* Leap Therapeutics Inc  LPTX.OQ  reported a quarterly
adjusted
loss of 46 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-1.00.  The mean expectation of four analysts
for the quarter was for a loss of 55 cents per share. Wall
Street expected results to range from -56 cents to -53 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Leap Therapeutics Inc's reported EPS for the quarter was a
loss
of 46 cents​.
    * The company reported a quarterly loss of $12.47 million.
    * Leap Therapeutics Inc shares had fallen by 46.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Leap
Therapeutics
Inc is $14.25 

This summary was machine generated from LSEG data March 18 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.55          -0.46          Beat
 Sep. 30 2023      -0.58          -0.51          Beat
 Jun. 30 2023      -0.90          -0.91          Missed
 Mar. 31 2023      -0.98          -3.20          Missed